For example, the integration of prostate-specific antigen (PSA) testing, risk calculators, and MRI scans has led to standardized pathways for early detection of prostate cancer, streamlining information gathering and reducing unnecessary biopsies and overdiagnosis [1,2,3,4,5,6,7,8]. This evidence concerns the gene KLK3 and prostate cancer.